Sensitivity and specificity of the 'Awaji' electrodiagnostic criteria for amyotrophic lateral sclerosis: Retrospective comparison of the Awaji and revised El Escorial criteria for ALS

• Published in: Amyotrophic lateral sclerosis Vol. 11; no. 6; pp. 497 - 501
• Main Authors: Boekestein, Werner A., Kleine, Bert U., Hageman, G., Schelhaas, Helenius J., Zwarts, Machiel J.
• Format: Journal Article
• Language: English
• Published: England Informa Healthcare 01.12.2010; Taylor & Francis
• Subjects: Amyotrophic Lateral Sclerosis - diagnosis; Amyotrophic Lateral Sclerosis - physiopathology; Awaji; diagnostic study; El Escorial criteria; Electromyography - standards; EMG; Guidelines as Topic; Humans; lower motor neuron signs; Neural Conduction; Retrospective Studies; Sensitivity and Specificity; STARD
• ISSN: 1748-2968; 1471-180X
• DOI: 10.3109/17482961003777462

Abstract The Awaji Commission recently proposed a modification of the electrodiagnostic criteria for ALS. We assessed whether the Awaji recommendations improve the sensitivity of the early diagnosis of ALS. In a retrospective study we reviewed clinical and neurophysiological data for 213 patients who visited our motor neuron disease outpatient clinic between October 2006 and December 2008. Using the El Escorial criteria, 51 patients were diagnosed with definite or probable ALS, 14 with probable laboratory-supported ALS, and 28 with possible ALS. An alternative diagnosis was present in 120 patients. Applying the Awaji recommendations, 66 patients were diagnosed with either definite or probable ALS, and 27 with possible ALS. Of the 14 patients diagnosed with probable laboratory-supported ALS, eight switched to probable ALS and six to possible ALS using the Awaji recommendations; none of the patients with an ALS mimic was diagnosed with ALS according to the Awaji recommendations. In conclusion, the new criteria for ALS do not result in a loss of specificity and can potentially improve the sensitivity by 16%. However, this diagnostic improvement appears eliminated if patients with probable laboratory-supported ALS - due to UMN signs in one region - should be categorized as possible ALS.